Intraoperative Frozen Section via Neurosafe During Robotic Radical Prostatectomy in the Era of Preoperative Risk Stratifications and Primary Staging With mpMRI and PSMA-PET CT: Is There a Perfect Candidate?

Multiparametric MRI PSMA Peroperative frozen Prostate cancer Robotics

Journal

Clinical genitourinary cancer
ISSN: 1938-0682
Titre abrégé: Clin Genitourin Cancer
Pays: United States
ID NLM: 101260955

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 16 04 2023
revised: 01 06 2023
accepted: 25 06 2023
pubmed: 15 7 2023
medline: 15 7 2023
entrez: 14 7 2023
Statut: ppublish

Résumé

We aimed to analyze the effect of preoperative risk assessment including Ga-68 PSMA PET and multiparametric magnetic resonance imaging (mpMRI) on nerve sparing practices, positive surgical margin (PSM) rates and oncological outcomes based on a comparison between patients underwent RARP with and without Neurosafe (NS). Patients underwent RARP with NS (RARP-NS) or without (RARP-only) NS retrospectively evaluated. Suspicion for extracapsular extension on mpMRI and/or Ga-68 PSMA PET was recorded as i(imaging)T3. NS was performed according to the Martini-Klinik technique. PSM at preserved bundle side were called PSM at region of interest (ROI) while the others were elsewhere. A total of 208 patients (90 in RARP-NS, 118 in RARP-only groups) were included. Preoperatively the RARP-only group showed significantly higher mean PSA (p = .01) and PIRADS 5 (p = .002) findings and had more D'Amico high risk (DAHR) patients (p = .08). The overall PSM rates for pT2 versus pT3 disease were 7.5% versus 21.6 and 15.6% versus 55% in RARP-NS and RARP-only groups, respectively. NS resulted in more bilaterally preserved bundles (81.1% vs. 66.3%) and less PSM at the ROI (3.3% vs. 23.4%) than RARP-only group. NS outperformed RARP-only in all clinical settings had its highest differential benefit in more bilateral nerve sparing and less PSM at ROI in patients with both DAHR and iT3 disease. BCR rates were 2.2% and 2.5% for RARP-NS and RARP only groups, respectively (p = .4). One patient in RARP-NS and 9 in RARP-only groups had PSA persistence (p = .02). RARP-NS led to more preserved bundles with less PSM. It was especially useful in DAHR patients with preoperative extracapsular extension suspicion in imaging simultaneously.

Sections du résumé

BACKGROUND BACKGROUND
We aimed to analyze the effect of preoperative risk assessment including Ga-68 PSMA PET and multiparametric magnetic resonance imaging (mpMRI) on nerve sparing practices, positive surgical margin (PSM) rates and oncological outcomes based on a comparison between patients underwent RARP with and without Neurosafe (NS).
METHODS METHODS
Patients underwent RARP with NS (RARP-NS) or without (RARP-only) NS retrospectively evaluated. Suspicion for extracapsular extension on mpMRI and/or Ga-68 PSMA PET was recorded as i(imaging)T3. NS was performed according to the Martini-Klinik technique. PSM at preserved bundle side were called PSM at region of interest (ROI) while the others were elsewhere.
RESULTS RESULTS
A total of 208 patients (90 in RARP-NS, 118 in RARP-only groups) were included. Preoperatively the RARP-only group showed significantly higher mean PSA (p = .01) and PIRADS 5 (p = .002) findings and had more D'Amico high risk (DAHR) patients (p = .08). The overall PSM rates for pT2 versus pT3 disease were 7.5% versus 21.6 and 15.6% versus 55% in RARP-NS and RARP-only groups, respectively. NS resulted in more bilaterally preserved bundles (81.1% vs. 66.3%) and less PSM at the ROI (3.3% vs. 23.4%) than RARP-only group. NS outperformed RARP-only in all clinical settings had its highest differential benefit in more bilateral nerve sparing and less PSM at ROI in patients with both DAHR and iT3 disease. BCR rates were 2.2% and 2.5% for RARP-NS and RARP only groups, respectively (p = .4). One patient in RARP-NS and 9 in RARP-only groups had PSA persistence (p = .02).
CONCLUSION CONCLUSIONS
RARP-NS led to more preserved bundles with less PSM. It was especially useful in DAHR patients with preoperative extracapsular extension suspicion in imaging simultaneously.

Identifiants

pubmed: 37451883
pii: S1558-7673(23)00154-4
doi: 10.1016/j.clgc.2023.06.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

602-611

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Ersin Köseoğlu (E)

Department of Urology, Koç University School of Medicine, Istanbul, Turkey. Electronic address: ekoseoglu@kuh.ku.edu.tr.

İbrahim Kulaç (İ)

Department of Pathology, Koç University School of Medicine, Istanbul, Turkey.

Ayşe Armutlu (A)

Department of Pathology, Koç University School of Medicine, Istanbul, Turkey.

Bengi Gürses (B)

Department of Radiology, Koç University School of Medicine, Istanbul, Turkey.

Hülya Seymen (H)

Department of Nuclear Medicine, Koç University School of Medicine, Istanbul, Turkey.

Metin Vural (M)

Radiology Clinic, VKF American Hospital, Istanbul, Turkey.

İbrahim Can Aykanat (İC)

Urology Clinic, Koç University Hospital, Istanbul, Turkey.

Kayhan Tarım (K)

Department of Urology, Koç University School of Medicine, Istanbul, Turkey.

Ahmet Furkan Sarıkaya (AF)

Department of Urology, Koç University School of Medicine, Istanbul, Turkey.

Mert Kılıç (M)

Urology Clinic, VKF American Hospital, Istanbul, Turkey.

Dilek Ertoy Baydar (DE)

Department of Pathology, Koç University School of Medicine, Istanbul, Turkey.

Mehmet Onur Demirkol (MO)

Department of Nuclear Medicine, Koç University School of Medicine, Istanbul, Turkey.

Mevlana Derya Balbay (MD)

Department of Urology, Koç University School of Medicine, Istanbul, Turkey; Urology Clinic, VKF American Hospital, Istanbul, Turkey.

Yakup Kordan (Y)

Department of Urology, Koç University School of Medicine, Istanbul, Turkey.

Abdullah Erdem Canda (AE)

Department of Urology, Koç University School of Medicine, Istanbul, Turkey.

Tarık Esen (T)

Department of Urology, Koç University School of Medicine, Istanbul, Turkey; Urology Clinic, VKF American Hospital, Istanbul, Turkey.

Classifications MeSH